Literature DB >> 19101728

Tumor with watery diarrhoea, hypokalaemia in a 3-year-old girl.

Wei-Qiang Zhang1, Ji-Fu Liu, Jing Zhao, Shu-Yu Zhao, Yun Xue.   

Abstract

Watery diarrhoea, hypokalaemia and achlorhydria (WDHA) syndrome was caused by vasoactive intestinal polypeptide (VIP)-producing tumour. A 3-year-old Chinese girl with watery diarrhoea, abdominal distension and hypokalaemia due to a thoracic paraspinal VIP-secreting ganglioneuroma is reported. The girl coughed, fevering up to 39 degrees C after a flu-like episode. She had eight to ten abundant stools daily which is not improved by dietary treatment, resulting in an important weight loss. She weighed 6.8 kg (nl P50 at 6 months of age) and is 76 cm (nl P50 at 9 months of age) in height. Blood electrolytes showed 129 mmol/L sodium, 2.42 mmol/L potassium, 94 mmol/L chloride and 18.6 mmol/L bicarbonate; urinary catecholamines were normal. Computed tomography scan evidenced a left side paravertebral mass of 4 x 6 cm in the lower thoracic region leading to the blood determination of vasoactive intestinal polypeptide which amounted 830 pmol/L(normal < 25 pmol/L). Surgical removal showed a ganglioneuroma of 160 g and was associated with disappearance of the diarrhoea and normalization of VIP level below 20 pmol/L. Review of the 63 reported cases in children with WDHA showed that many of the cases presented with non-treatable watery diarrhoea, hypokalaemia. Achlorhydria is not necessarily part of the WDHA syndrome. The male to female ratio is 1:1.5. Ganglioneuroblastoma and ganglioneuroma are the commonest tumours. Location of the tumour is variable: abdomen, chest or neck. Abdominal distension, flushing, episodic hypertension and colonic dilatation, constipation and ataxia were the other associated features. Surgical resection is the treatment of choice of VIP-producing tumours.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101728     DOI: 10.1007/s00431-008-0898-4

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors.

Authors:  S I Said; G R Faloona
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

2.  Islet cell tumor of the pancreas with reversible watery diarrhea and achylorhydraia.

Authors:  I N Marks; S Bank; J H Louw
Journal:  Gastroenterology       Date:  1967-04       Impact factor: 22.682

3.  Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.

Authors:  S M Wood; M E Kraenzlin; T E Adrian; S R Bloom
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

4.  trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.

Authors:  T Tanaka; E Hiyama; T Sugimoto; T Sawada; M Tanabe; N Ida
Journal:  Cancer       Date:  1995-09-15       Impact factor: 6.860

5.  Watery diarrhoea and ganglioneuroma with secretion of vasoactive intestinal peptide.

Authors:  P G Swift; S R Bloom; F Harris
Journal:  Arch Dis Child       Date:  1975-11       Impact factor: 3.791

6.  Paraneoplastic syndromes in ganglioneuroblastoma: contrasting symptoms of constipation and diarrhoea.

Authors:  Barbara Wildhaber; Felix Niggli; Eva Bergsträsser; Thomas Stallmach; Peter Sacher
Journal:  Eur J Pediatr       Date:  2003-05-09       Impact factor: 3.183

7.  Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors.

Authors:  S J Qualman; M S O'Dorisio; D J Fleshman; H Shimada; T M O'Dorisio
Journal:  Cancer       Date:  1992-10-01       Impact factor: 6.860

8.  [The VIP-secreting tumor as a differential diagnosis of protracted diarrhea in pediatrics].

Authors:  T Reindl; P Degenhardt; W Luck; T Riebel; N Sarioglu; G Henze; P Hernáiz Driever
Journal:  Klin Padiatr       Date:  2004 Sep-Oct       Impact factor: 1.349

9.  Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).

Authors:  R G Long; M G Bryant; S J Mitchell; T E Adrian; J M Polak; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

10.  In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide.

Authors:  J C Pence; N A Shorter
Journal:  Cancer Res       Date:  1990-08-15       Impact factor: 12.701

View more
  3 in total

1.  Vasoactive intestinal peptide releasing tumor which caused to chronic watery diarrhea and hypokalemia.

Authors:  Ali Kanık; Maşallah Baran; Özlem Çayan; Kayı Eliaçık; Tunç Özdemir; Mehmet Helvacı; Emre Çeçen
Journal:  Turk Pediatri Ars       Date:  2014-06-01

Review 2.  Incidental ganglioneuromas: a presentation of 14 surgical cases and literature review.

Authors:  C Spinelli; L Rossi; A Barbetta; C Ugolini; S Strambi
Journal:  J Endocrinol Invest       Date:  2014-12-13       Impact factor: 4.256

3.  Uncommon reasons of the digestive tract-related paraneoplastic syndromes in children with neuroblastic tumors: three case reports.

Authors:  Elżbieta Czkwianianc; Beata Zalewska-Szewczyk; Józef Kobos; Anna Socha-Banasiak; Szymon Janczar; Sylwia Prymus-Kasińska; Joanna Kazanek-Zasada; Wojciech Młynarski
Journal:  Contemp Oncol (Pozn)       Date:  2018-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.